FDA Inspection 1203574 — AGC Biologics A/S

AGC Biologics A/S — FEI 3004708748

The FDA completed an inspection of AGC Biologics A/S on Apr 22, 2021 in Soborg. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 22, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Soborg (Denmark)

Additional Details

Mutual Recognition Agreement (MRA)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.